Andrew Senn will take Mr. Khales’ place as the President, Cardio & Vascular at the same time. Khales joined the Company in early 2018 and has served as the President, Cardio & Vascular.
Payman Khales will become Chief Operating Officer, and Andrew Senn will take over as President of Cardio & Vascular. The company reported a 9% sales increase to $431 million and a 29% rise in GAAP ...
After the speakers' remarks, there will be a question-and-answer session [Operator Instructions] I would now like to turn the conference over to Andrew Senn, Senior Vice President of Strategy ...